Update date
31 Dec 2025
Shareable Research Card
GILD - GILEAD SCIENCES, INC. Share-based Payment Arrangement, Expense
This metric view shows GILD - GILEAD SCIENCES, INC. share-based payment arrangement, expense history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
- Context
- Latest reported period: 2025
- Latest reported value
- $894,000,000
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
Why revisit this metric view
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
- Latest source-backed update
- Latest period end 31 Dec 2025
- Why come back
- Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
- Current latest reported period: 2025.
- Latest reported value on this page: $894,000,000.
- Save this filer if you want to compare the next reported value with this history.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest update for Share-based Payment Arrangement, Expense
Latest reported share-based payment arrangement, expense: $894,000,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Page type
Metric history
Latest period
2025
Ownership context was refreshed from SEC Forms 3/4/5 filed on 27 May 2026.
Benchmark Context
How Share-based Payment Arrangement, Expense compares with peers
GILEAD SCIENCES, INC. sits in the top quarter of the current share-based payment arrangement, expense sample.
Compared with
Compared with 120 companies reporting share-based payment arrangement, expense in USD. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 2.2x the current sample midpoint. Share-based Payment Arrangement, Expense is down about 7.7% versus the comparable prior period.
- Visible rows currently span reported period ends from 31 Dec 2012 to 30 Apr 2026.
- Nearby companies in this sample: CISCO SYSTEMS, INC. and PFIZER INC.
- Current sample position: rank #25 of 120 comparable companies.
- Peer rows use the latest valid value per company for this exact metric and compatible units.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
GILEAD SCIENCES, INC.: Share-based Payment Arrangement, Expense
Latest period: 2025. Period end: 31 Dec 2025. Units: USD. Frequency: annual and quarterly.
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Metric Snapshot
- Latest value
- $894,000,000
- Coverage range
- 31 Mar 2010 - 31 Dec 2025
- Fact rows
- 40
What This Metric Tells You
- Shows reported share-based payment arrangement, expense over 31 Mar 2010 - 31 Dec 2025.
- Includes year-over-year change points to highlight acceleration or slowdown.
- Built from 40 SEC fact rows for this metric and issuer.
How To Read This Chart
- Start with the latest point, then compare it with the prior periods to see direction.
- Use annual sequence to compare like-for-like periods.
- Use YoY change bars to separate growth from contraction across matching periods.
- Use the TTM line to smooth quarter-to-quarter noise.
Official SEC Source
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare This Metric Across Companies
Compare latest available Share-based Payment Arrangement, Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
GILEAD SCIENCES, INC. appears at rank #25 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | Telomir Pharmaceuticals, Inc. (telo) | $39,803,000,000 | Quarter - 31 Mar 2026 | Open Telomir Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense |
| 2 | Meta Platforms, Inc. (meta) | $20,427,000,000 | Year - 31 Dec 2025 | Open Meta Platforms, Inc. Share-based Payment Arrangement, Expense |
| 3 | MICROSOFT CORP (msft) | $11,974,000,000 | Year - 30 Jun 2025 | Open MICROSOFT CORP Share-based Payment Arrangement, Expense |
| 4 | Alphabet Inc. (googl) | $7,200,000,000 | Quarter - 31 Mar 2026 | Open Alphabet Inc. Share-based Payment Arrangement, Expense |
| 5 | BANK OF AMERICA CORP /DE/ (bac) | $4,200,000,000 | Year - 31 Dec 2025 | Open BANK OF AMERICA CORP /DE/ Share-based Payment Arrangement, Expense |
| 6 | AMAZON COM INC (amzn) | $4,032,000,000 | Quarter - 31 Mar 2026 | Open AMAZON COM INC Share-based Payment Arrangement, Expense |
Metric Details
- Metric
- Share-based Payment Arrangement, Expense (AllocatedShareBasedCompensationExpense)
- Frequency coverage
- annual and quarterly
- Taxonomy
- us-gaap
- Units tracked
- USD
- History range
- 31 Mar 2010 - 31 Dec 2025
- Facts on this page
- 40
- Metric definition
- Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
- SEC metric endpoint
- Open SEC company concept
Metric identity
1 identity field
Metric coverage
3 source fields
How to read it
1 detail
Source evidence
1 source field
Chart Context
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
GILEAD SCIENCES, INC. Annual Share-based Payment Arrangement, Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $894,000,000 | -$75,000,000 | -7.7% | 01 Jan 2025 | 31 Dec 2025 | 10-K | 24 Feb 2026 | 2025 | FY |
| 2024 | $969,000,000 | +$173,000,000 | +22% | 01 Jan 2024 | 31 Dec 2024 | 10-K | 24 Feb 2026 | 2025 | FY |
| 2023 | $796,000,000 | +$151,000,000 | +23% | 01 Jan 2023 | 31 Dec 2023 | 10-K | 24 Feb 2026 | 2025 | FY |
| 2022 | $645,000,000 | +$10,000,000 | +1.6% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 28 Feb 2025 | 2024 | FY |
| 2021 | $635,000,000 | -$441,000,000 | -41% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 23 Feb 2024 | 2023 | FY |
| 2020 | $1,076,000,000 | +$440,000,000 | +69% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 22 Feb 2023 | 2022 | FY |
| 2019 | $636,000,000 | -$209,000,000 | -25% | 01 Jan 2019 | 31 Dec 2019 | 10-K | 23 Feb 2022 | 2021 | FY |
| 2018 | $845,000,000 | +$196,000,000 | +30% | 01 Jan 2018 | 31 Dec 2018 | 10-K | 25 Feb 2021 | 2020 | FY |
| 2017 | $649,000,000 | +$269,000,000 | +71% | 01 Jan 2017 | 31 Dec 2017 | 10-K | 25 Feb 2020 | 2019 | FY |
| 2016 | $380,000,000 | -$2,000,000 | -0.52% | 01 Jan 2016 | 31 Dec 2016 | 10-K | 26 Feb 2019 | 2018 | FY |
| 2015 | $382,000,000 | +$22,000,000 | +6.1% | 01 Jan 2015 | 31 Dec 2015 | 10-K | 27 Feb 2018 | 2017 | FY |
| 2014 | $360,000,000 | +$108,000,000 | +43% | 01 Jan 2014 | 31 Dec 2014 | 10-K | 27 Feb 2017 | 2016 | FY |
| 2013 | $252,000,000 | -$151,000,000 | -37% | 01 Jan 2013 | 31 Dec 2013 | 10-K | 24 Feb 2016 | 2015 | FY |
| 2012 | $403,000,000 | +$210,622,000 | +109% | 01 Jan 2012 | 31 Dec 2012 | 10-K | 25 Feb 2015 | 2014 | FY |
| 2011 | $192,378,000 | -$7,663,000 | -3.8% | 01 Jan 2011 | 31 Dec 2011 | 10-K | 25 Feb 2014 | 2013 | FY |
| 2010 | $200,041,000 | 01 Jan 2010 | 31 Dec 2010 | 10-K | 27 Feb 2013 | 2012 | FY |
GILEAD SCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | $382,000,000 | $97,000,000 | +$2,000,000 | +2.1% | 01 Oct 2015 | 31 Dec 2015 | 10-K | 27 Feb 2018 | 2017 | FY |
| Q3 2015 | $380,000,000 | $97,000,000 | -$3,000,000 | -3% | 01 Jul 2015 | 30 Sep 2015 | 10-Q | 04 Nov 2015 | 2015 | Q3 |
| Q2 2015 | $383,000,000 | $96,000,000 | +$13,000,000 | +16% | 01 Apr 2015 | 30 Jun 2015 | 10-Q | 05 Aug 2015 | 2015 | Q2 |
| Q1 2015 | $370,000,000 | $92,000,000 | +$10,000,000 | +12% | 01 Jan 2015 | 31 Mar 2015 | 10-Q | 08 May 2015 | 2015 | Q1 |
| Q4 2014 | $360,000,000 | $95,000,000 | +$23,293,000 | +32% | 01 Oct 2014 | 31 Dec 2014 | 10-K | 27 Feb 2017 | 2016 | FY |
| Q3 2014 | $336,707,000 | $100,000,000 | +$37,427,000 | +60% | 01 Jul 2014 | 30 Sep 2014 | 10-Q | 04 Nov 2015 | 2015 | Q3 |
| Q2 2014 | $299,280,000 | $83,000,000 | +$27,047,000 | +48% | 01 Apr 2014 | 30 Jun 2014 | 10-Q | 05 Aug 2015 | 2015 | Q2 |
| Q1 2014 | $272,233,000 | $82,000,000 | +$20,233,000 | +33% | 01 Jan 2014 | 31 Mar 2014 | 10-Q | 08 May 2015 | 2015 | Q1 |
| Q4 2013 | $252,000,000 | $71,707,000 | +$14,242,000 | +25% | 01 Oct 2013 | 31 Dec 2013 | 10-K | 24 Feb 2016 | 2015 | FY |
| Q3 2013 | $237,758,000 | $62,573,000 | +$8,109,000 | +15% | 01 Jul 2013 | 30 Sep 2013 | 10-Q | 05 Nov 2014 | 2014 | Q3 |
| Q2 2013 | $229,649,000 | $55,953,000 | +$7,550,000 | +16% | 01 Apr 2013 | 30 Jun 2013 | 10-Q | 04 Aug 2014 | 2014 | Q2 |
| Q1 2013 | $222,099,000 | $61,767,000 | -$180,901,000 | -75% | 01 Jan 2013 | 31 Mar 2013 | 10-Q | 07 May 2014 | 2014 | Q1 |
| Q4 2012 | $403,000,000 | $57,465,000 | +$11,202,000 | +24% | 01 Oct 2012 | 31 Dec 2012 | 10-K | 25 Feb 2015 | 2014 | FY |
| Q3 2012 | $391,798,000 | $54,464,000 | +$7,944,000 | +17% | 01 Jul 2012 | 30 Sep 2012 | 10-Q | 31 Oct 2013 | 2013 | Q3 |
| Q2 2012 | $383,854,000 | $48,403,000 | -$1,722,000 | -3.4% | 01 Apr 2012 | 30 Jun 2012 | 10-Q | 01 Aug 2013 | 2013 | Q2 |
| Q1 2012 | $385,576,000 | $242,668,000 | +$193,198,000 | +391% | 01 Jan 2012 | 31 Mar 2012 | 10-Q | 08 May 2013 | 2013 | Q1 |
| Q4 2011 | $192,378,000 | $46,263,000 | -$7,088,000 | -13% | 01 Oct 2011 | 31 Dec 2011 | 10-K | 25 Feb 2014 | 2013 | FY |
| Q3 2011 | $199,466,000 | $46,520,000 | -$5,282,000 | -10% | 01 Jul 2011 | 30 Sep 2011 | 10-Q | 06 Nov 2012 | 2012 | Q3 |
| Q2 2011 | $204,748,000 | $50,125,000 | +$2,078,000 | +4.3% | 01 Apr 2011 | 30 Jun 2011 | 10-Q | 01 Aug 2012 | 2012 | Q2 |
| Q1 2011 | $202,670,000 | $49,470,000 | +$2,629,000 | +5.6% | 01 Jan 2011 | 31 Mar 2011 | 10-Q | 04 May 2012 | 2012 | Q1 |
| Q4 2010 | $200,041,000 | $53,351,000 | 01 Oct 2010 | 31 Dec 2010 | 10-K | 27 Feb 2013 | 2012 | FY | ||
| Q3 2010 | $51,802,000 | 01 Jul 2010 | 30 Sep 2010 | 10-Q | 04 Nov 2011 | 2011 | Q3 | |||
| Q2 2010 | $48,047,000 | 01 Apr 2010 | 30 Jun 2010 | 10-Q | 05 Aug 2011 | 2011 | Q2 | |||
| Q1 2010 | $46,841,000 | 01 Jan 2010 | 31 Mar 2010 | 10-Q | 09 May 2011 | 2011 | Q1 |
* marks a reported value that did not pass the local value check.